Acrux ARUXF Stock
Acrux Price Chart
Acrux ARUXF Financial and Trading Overview
| Acrux stock price | 0.02 USD |
| Previous Close | 0.02 USD |
| Open | 0.02 USD |
| Bid | 0.0051 USD x 4000000 |
| Ask | 0.03 USD x 2000000 |
| Day's Range | 0.02 - 0.02 USD |
| 52 Week Range | 0.001 - 0.05 USD |
| Volume | 40K USD |
| Avg. Volume | 1.79K USD |
| Market Cap | 8.83M USD |
| Beta (5Y Monthly) | 0.987 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | August 18, 2015 |
| 1y Target Est | N/A |
ARUXF Valuation Measures
| Enterprise Value | 8.19M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 3.1411405 |
| Price/Book (mrq) | 7.962871 |
| Enterprise Value/Revenue | 2.915 |
| Enterprise Value/EBITDA | -1.48 |
Trading Information
Acrux Stock Price History
| Beta (5Y Monthly) | 0.987 |
| 52-Week Change | -57.75% |
| S&P500 52-Week Change | 22.66% |
| 52 Week High | 0.05 USD |
| 52 Week Low | 0.001 USD |
| 50-Day Moving Average | 0.01 USD |
| 200-Day Moving Average | 0.01 USD |
ARUXF Share Statistics
| Avg. Volume (3 month) | 1.79K USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 522.28M |
| Float | 309.27M |
| Short Ratio | N/A |
| % Held by Insiders | 18.57% |
| % Held by Institutions | 8.77% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2025 |
| Most Recent Quarter (mrq) | December 31, 2025 |
| Next Fiscal Year End | June 30, 2026 |
Profitability
| Profit Margin | -83.80% |
| Operating Margin (ttm) | -102.29% |
| Gross Margin | 45.58% |
| EBITDA Margin | -196.93% |
Management Effectiveness
| Return on Assets (ttm) | -57.22% |
| Return on Equity (ttm) | -102.19% |
Income Statement
| Revenue (ttm) | 2.81M USD |
| Revenue Per Share (ttm) | 0.007 USD |
| Quarterly Revenue Growth (yoy) | 1350.00% |
| Gross Profit (ttm) | 1.28M USD |
| EBITDA | -5534000 USD |
| Net Income Avi to Common (ttm) | -2355000 USD |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 946K USD |
| Total Cash Per Share (mrq) | 0.002 USD |
| Total Debt (mrq) | 2.2M USD |
| Total Debt/Equity (mrq) | 183.17 USD |
| Current Ratio (mrq) | 1.348 |
| Book Value Per Share (mrq) | 0.00212235 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -2441000 USD |
| Levered Free Cash Flow (ttm) | -4449250 USD |
Profile of Acrux
| Country | United States |
| State | VIC |
| City | West Melbourne |
| Address | 103-113, Stanley Street |
| ZIP | 3003 |
| Phone | 61 3 8379 0100 |
| Website | https://www.acrux.com.au |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Acrux Limited, together with its subsidiaries, develops and commercializes generic and topically applied pharmaceutical products in Australia, Europe, the United States, and internationally. The company provides estradiol transdermal sprays to women for the treatment of flushes associated with menopause under the Evamist and Lenzetto brand names; Dapsone 5% and Dapsone 7.5%, which are gels for the treatment of acne vulgaris; and Lidocaine and Prilocaine Cream USP, a topical anesthetic cream. It is also involved in the development of Efinaconazole, a topical solution used to treat fungal infections of toenails; Nitroglycerin 0.4%, an ointment for the treatment of pain associated with chronic anal fissure; and Acyclovir 5%, a cream for the treatment of cold sores. The company was incorporated in 1998 and is based in West Melbourne, Australia.
Q&A For Acrux Stock
What is a current ARUXF stock price?
Acrux ARUXF stock price today per share is 0.02 USD.
How to purchase Acrux stock?
You can buy ARUXF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Acrux?
The stock symbol or ticker of Acrux is ARUXF.
Which industry does the Acrux company belong to?
The Acrux industry is Biotechnology.
How many shares does Acrux have in circulation?
The max supply of Acrux shares is 522.28M.
What is Acrux Price to Earnings Ratio (PE Ratio)?
Acrux PE Ratio is now.
What was Acrux earnings per share over the trailing 12 months (TTM)?
Acrux EPS is 0 USD over the trailing 12 months.
Which sector does the Acrux company belong to?
The Acrux sector is Healthcare.